MacroGenics, Inc. (MGNX): Price and Financial Metrics
MacroGenics, Inc. (MGNX)
Today's Latest Price: $19.41 USD
Updated Oct 30 4:00pm
Add MGNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
MGNX Stock Summary
- Of note is the ratio of Macrogenics Inc's sales and general administrative expense to its total operating expenses; just 8.73% of US stocks have a lower such ratio.
- With a price/sales ratio of 13.49, Macrogenics Inc has a higher such ratio than 89.52% of stocks in our set.
- In terms of volatility of its share price, MGNX is more volatile than 91.95% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Macrogenics Inc, a group of peers worth examining would be MORF, VBLT, CARA, GRTS, and NTLA.
- Visit MGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.macrogenics.com.
MGNX Stock Price Chart Interactive Chart >
MGNX Price/Volume Stats
| Current price | $19.41 | 52-week high | $32.18 |
| Prev. close | $19.87 | 52-week low | $4.04 |
| Day low | $18.90 | Volume | 511,300 |
| Day high | $19.66 | Avg. volume | 1,337,448 |
| 50-day MA | $25.51 | Dividend yield | N/A |
| 200-day MA | $19.01 | Market Cap | 1.05B |
MacroGenics, Inc. (MGNX) Company Bio
Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.
Loading social stream, please wait...